| Ryan Poindexter, | |
|
1500 W Kingshighway, Paragould, AR 72450-4009 | |
| (870) 240-8053 | |
| Not Available |
| Full Name | Ryan Poindexter |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1500 W Kingshighway, Paragould, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497207088 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD09751 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Poindexter, 1500 W Kingshighway, Paragould, AR 72450-4009 Ph: () - | Ryan Poindexter, 1500 W Kingshighway, Paragould, AR 72450-4009 Ph: (870) 240-8053 |
News Archive
A new £1.1million trial led by the University of Stirling will assess whether a self-management program could help to improve the lives of women who suffer pelvic organ prolapse.
The National Institutes of Health's National Heart, Lung, and Blood Institute will fund a $1 million collaborative study by the Center for Natural Medicine and Prevention at Maharishi University of Management Research Institute and Columbia University Medical Center to determine whether the stress-reducing Transcendental Meditation technique can help patients with coronary heart disease (CHD) prevent future heart attacks, strokes and death.
In an effort to further individualize therapy and avoid over-treating patients, researchers at the Johns Hopkins Kimmel Cancer Center report a new study using PET scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy.
The amount of anesthetic required for general anesthesia during surgery varies widely from patient to patient and some may be able to receive a lower dose than typically administered, suggests a study being presented at the ANESTHESIOLOGY® 2015 annual meeting.
Ambrx Inc, and Merck Serono have announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis.
› Verified 5 days ago
Dr. Dayton Allen Neal, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1501 W Kingshighway, Paragould, AR 72450 Phone: 870-240-8405 | |
Jessica Lynn Mills, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2802 W Kingshighway, Paragould, AR 72450 Phone: 870-236-7785 | |
Twana Watkins, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 612 W Mueller, Paragould, AR 72450 Phone: 870-236-6369 | |
Mr. Steve E Smoker, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 W Kingshighway, Paragould, AR 72450 Phone: 870-239-4036 Fax: 870-239-9478 | |
Dr. Jeremy Hancock, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3104 W Kingshighway, Paragould, AR 72450 Phone: 870-236-6118 Fax: 870-236-5886 | |
Chelsea Paige Harvey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 W Kingshighway, Paragould, AR 72450 Phone: 870-239-4036 | |
Dr. Jeremy A Jones, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1500 W Kingshighway, Paragould, AR 72450 Phone: 870-240-8053 Fax: 870-240-8104 |